Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Sponsors
/ Biotec Pharmacon ASA
Biotec Pharmacon ASA
Industry · 9 registered clinical trials.
Status
Trial
Phase
Started
Completed
Evaluation of Woulgan in Diabetic Foot Ulcer
Diabetic Foot Ulcers
Phase 4
2015-10-01
Completed
Efficacy and Safety Study of Soluble Beta-1,3/1,6-glucan (SBG) Versus Placebo in Chronic Diabetic Foot Ulcers
Diabetes, Diabetic Ulcer
Phase 3
2008-10-01
Completed
Efficacy and Safety Study of SBG vs Placebo in Head and Neck Cancer Patients Undergoing Radiation Therapy
Head and Neck Cancer, Oral Mucositis
Phase 3
2008-10-01
Completed
Safety of Soluble Beta-Glucan (SBG) in Treatment of Patients With Non-Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma
Phase 1
2007-09-01
Completed
Soluble Beta-glucan (SBG) as Treatment for Diabetic Foot Ulcers
Chronic Diabetic Foot Ulcers
Phase 3
2007-03-01
Completed
Effect of SBG in Patients With Breast Cancer
Breast Cancer
Phase 1 / Phase 2
2007-01-01
Terminated
Efficacy and Safety Study of Soluble Beta-1,3/1,6-Glucan in Thermal Burns
Burns
Phase 1
2006-01-01
Completed
Efficacy of Soluble Beta-1,3/1,6-Glucan Compared to Placebo on Chronic Leg Ulcers in Diabetes Patients
Foot Ulcer
Phase 2
2005-06-01
Completed
The Protective Effect of Soluble Beta-1,3/1,6-Glucan Compared to Placebo in Oral Mucositis in Head and Neck Ca
Oral Mucositis
Phase 2
2003-10-01